178 related articles for article (PubMed ID: 26522770)
1. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
[TBL] [Abstract][Full Text] [Related]
2. Structure Elucidation of Coxsackievirus A16 in Complex with GPP3 Informs a Systematic Review of Highly Potent Capsid Binders to Enteroviruses.
De Colibus L; Wang X; Tijsma A; Neyts J; Spyrou JA; Ren J; Grimes JM; Puerstinger G; Leyssen P; Fry EE; Rao Z; Stuart DI
PLoS Pathog; 2015 Oct; 11(10):e1005165. PubMed ID: 26485389
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
5. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
6. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
He SJ; Han JF; Ding XX; Wang YD; Qin CF
Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5' untranslated region and VP1 region.
Zhou F; Kong F; Wang B; McPhie K; Gilbert GL; Dwyer DE
J Med Microbiol; 2011 Mar; 60(Pt 3):349-358. PubMed ID: 21148280
[TBL] [Abstract][Full Text] [Related]
9. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.
Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C
Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.
Zhang M; Wang Y; He W; Sun Y; Guo Y; Zhong W; Gao Q; Liao M; Wang X; Cai Y; Guo Y; Rao Z
J Med Chem; 2020 Feb; 63(3):1233-1244. PubMed ID: 31939669
[TBL] [Abstract][Full Text] [Related]
11. Human enterovirus 71 uncoating captured at atomic resolution.
Lyu K; Ding J; Han JF; Zhang Y; Wu XY; He YL; Qin CF; Chen R
J Virol; 2014 Mar; 88(6):3114-26. PubMed ID: 24352461
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
[TBL] [Abstract][Full Text] [Related]
13. Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
Zeng S; Meng X; Huang Q; Lei N; Zeng L; Jiang X; Guo X
Int J Antimicrob Agents; 2019 Apr; 53(4):362-369. PubMed ID: 30599241
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
[TBL] [Abstract][Full Text] [Related]
15. Synonymous codon usage analysis of hand, foot and mouth disease viruses: A comparative study on coxsackievirus A6, A10, A16, and enterovirus 71 from 2008 to 2015.
Su W; Li X; Chen M; Dai W; Sun S; Wang S; Sheng X; Sun S; Gao C; Hou A; Zhou Y; Sun B; Gao F; Xiao J; Zhang Z; Jiang C
Infect Genet Evol; 2017 Sep; 53():212-217. PubMed ID: 28602802
[TBL] [Abstract][Full Text] [Related]
16.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
17. Improved detection limit in rapid detection of human enterovirus 71 and coxsackievirus A16 by a novel reverse transcription-isothermal multiple-self-matching-initiated amplification assay.
Ding X; Nie K; Shi L; Zhang Y; Guan L; Zhang D; Qi S; Ma X
J Clin Microbiol; 2014 Jun; 52(6):1862-70. PubMed ID: 24648558
[TBL] [Abstract][Full Text] [Related]
18. Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding.
Lin CJ; Liu CH; Wang JY; Lin CC; Li YF; Richardson CD; Lin LT
Emerg Microbes Infect; 2018 Sep; 7(1):162. PubMed ID: 30254193
[TBL] [Abstract][Full Text] [Related]
19. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
[TBL] [Abstract][Full Text] [Related]
20. Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening.
Zhang QY; Li JQ; Li Q; Zhang Y; Zhang ZR; Li XD; Zhang HQ; Deng CL; Yang FX; Xu Y; Zhang B
Virol Sin; 2024 Apr; 39(2):301-308. PubMed ID: 38452856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
